metoprine has been researched along with deoxyuridine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, O; Fyfe, MJ; Laszlo, J; Lee, L; Swedwick, D | 1 |
| Brown, OE; Frazer, T; Kutler, M; Laszlo, J; Sedwick, WD | 1 |
| Brown, OE; Frazer, TA; Fyfe, MJ; Kutler, M; Laszlo, J; Sedwick, WD | 1 |
| Galivan, J; Nimec, Z; Rhee, M | 1 |
| Brown, OE; Fyfe, MJ; Laszlo, J; Sedwick, WD | 1 |
| Browman, GP; Calvert, AH; Harrap, KR; Hart, LI; Taylor, GA | 1 |
| Brown, OE; Hamrell, M; Laszlo, J; Sedwick, WD | 1 |
| Laszlo, J; Sedwick, WD | 1 |
8 other study(ies) available for metoprine and deoxyuridine
| Article | Year |
|---|---|
Comparison of metoprine (DDMP) and etoprine (DDEP) by measuring the inhibition of deoxyuridine incorporation into the DNA of human leukemic cells 1,2,3.
Topics: Antineoplastic Agents; Cells, Cultured; Deoxyuridine; Depression, Chemical; DNA, Neoplasm; Humans; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Pyrimethamine; Time Factors | 1978 |
New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
Topics: Cell Line; Cell Survival; Deoxyuridine; Dose-Response Relationship, Drug; Folic Acid Antagonists; Humans; Leucovorin; Leukemia; Methotrexate; Pyrimethamine; Time Factors | 1979 |
Deoxyuridine incorporation as a useful measure of methotrexate and metoprine uptake and metabolic effectiveness.
Topics: Deoxyuridine; Folic Acid Antagonists; Humans; Kinetics; Methotrexate; Pyrimethamine; Time Factors | 1979 |
Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Deoxyuridine; Folic Acid; Folic Acid Antagonists; Liver Neoplasms, Experimental; Methotrexate; Pyrimethamine; Quinazolines; Rats; Thymidine; Thymidylate Synthase; Trimetrexate | 1987 |
Human plasma and amino acids as moderators of uptake and metabolic consequences of antifolates in WIL-2 and human leukemia cells.
Topics: Amino Acids; Blood; Cell Line; Culture Media; Deoxyuridine; Folic Acid Antagonists; Glutamine; Humans; Kinetics; Leukemia; Lymphocytes; Methotrexate; Pyrimethamine | 1981 |
The intracellular mechanism of action of metoprine (DDMP).
Topics: Animals; Cell Survival; Cells, Cultured; Deoxyuridine; Dose-Response Relationship, Drug; Drug Resistance; Folic Acid Antagonists; Leucovorin; Leukemia L1210; Methotrexate; Mice; Purines; Pyrimethamine; Pyrimidines; Thymidine | 1980 |
Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
Topics: Cell Line; Clone Cells; Deoxyuridine; Folic Acid Antagonists; Kinetics; Methotrexate; Phosphorus Radioisotopes; Pyrimethamine; Tetrahydrofolate Dehydrogenase | 1981 |
An antifolate-induced lesion in newly synthesized DNA.
Topics: Cell Line; Cell Survival; Deoxyuridine; DNA; Folic Acid Antagonists; Humans; Methotrexate; Molecular Weight; Pyrimethamine; Thymidine | 1980 |